Development Partnering

Because Phazemos uses an ecosystem business model, we are configured to bring different groups together to solve common problems.

Each of the companies on our platform comes not only with unique R&D expertise and experience that can support your research, but also with connections to industry players that can help in other ways - like providing connections to capital. We've never been shy about tapping into these networks on your behalf.

In fact, we've taken it one step further and organized our substantial connections to the investment community so we can make them available to you as part of our partnering development solution.

Our ecosystem of smaller, best-of-breed service providers allows your to become it's own clinical-development concierge.

We collect extensive information on the experiences and expertise of our ecosystem members, and make it available to you at the touch of a button.

Plus, unlike more traditional mega-CROs, our partners don't have incentives that reward prioritization of large pharma companies over smaller biotech companies - they are fully aligned with your goals.

Technology is making it easier for biopharma, medtech and techbio companies to successfully complete more and more of their R&D in house.

But it is still critical to receive strategic advice from reliable, top-notch experts.

The Phazemos Ecosystem puts these experts within reach, without all of the overhead that comes with a CRO. Plus, we take it one step further by cataloguing expertise across a wide range of topics. If you can't find it through us, it probably doesn't exist.